<?xml version="1.0" encoding="UTF-8"?>
<p id="Par88">
 <list list-type="order">
  <list-item>
   <p id="Par89">Pregnancy or lactation at the time of study entry.</p>
  </list-item>
  <list-item>
   <p id="Par90">Evidence of more than one clone of metastatic disease e.g. ER-positive and ER-negative and or HER2-positive disease. (To exclude those with some ER-positive and some TNBC or HER2-positive disease).</p>
  </list-item>
  <list-item>
   <p id="Par91">Evidence of Leptomeningeal disease.</p>
  </list-item>
  <list-item>
   <p id="Par92">Evidence of Malignant cord compression.</p>
  </list-item>
  <list-item>
   <p id="Par93">Previous chemotherapy for metastatic disease (chemotherapy for primary breast cancer is allowed).</p>
  </list-item>
  <list-item>
   <p id="Par94">Contraindication to radiotherapy.</p>
  </list-item>
  <list-item>
   <p id="Par95">Previous radiotherapy in which the treated area planned to receive treatment is greater or equal to EQD2 40â€‰Gy.</p>
  </list-item>
  <list-item>
   <p id="Par96">Previous SRT to an oligoprogressive lesion.</p>
  </list-item>
  <list-item>
   <p id="Par97">Any condition deeming the patient unsuitable to comply with the study.</p>
  </list-item>
 </list>
</p>
